News Focus
News Focus
Followers 0
Posts 294
Boards Moderated 0
Alias Born 09/15/2016

Re: johnnyblades2001 post# 1744

Saturday, 02/22/2020 7:13:12 AM

Saturday, February 22, 2020 7:13:12 AM

Post# of 3653
The patent zombies strike again: apples to oranges comparison

Any halfway-informed person reading the back and forth on the patent issue can instantly appreciate that Venturis Therapeutics is presenting appples to oranges, brain-eaten zombie arguments about the immense value of its patents (likely by its leadership writing here anonymously, which is funny because many have reported that company leadership doesn't return actual shareholder phone calls).

The zombie suggestion that the purchase of any development-stage biotech company is linked to the number of patents it has proves only that there really are zombies and they will eat your brain. That's not how it works, and anyone who knows the first thing about biotech doesn't need to be told that. What matters in every one of the examples provided, which is not the case with Venturis Therapeutics, are the following:

1) The acquired development-stage companies have ongoing and advancing clinical trials. Venturis Therapeutics hasn't run a single clinical trial in 14 years and counting. In the eyes of everyone who is not Venturis Therapeutics leadership, this is a broken company and Humpty Dumpty can not be put back together again. Ever.

2) The companies acquired are financially solvent and not bankrupt as Venturis Therapeutics is (in all but name - and don't worry, that formal designation is coming very soon).

3) The companies acquired do not have leadership that is accused by the U.S. government of allegedly stealing $14 million (or any amount) from a previous company which was run into bankruptcy. Here's a truism: No one will as much as touch a company where there is even the whiff of fraud. In Venturis Therapeutics's case, it's not a whiff, it's a stench that is so overpowering you can smell it even over the Internet. Venturis Therapeutics's Chairman/President, Calvin Wallen III, is accused by the U.S. government bankruptcy trustee of fraud and of stealing $14 million from his previous company. As a result, everything about Venturis Therapeutics is radioactive and no one remotely credible will go near it. The end.

Can you say: zzzombie....zzzombie....zzzombie....zzzombie....zzzzzzzz.....

If you'd like to understand these issues in greater detail, here is more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153950894

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today